Replies to post #19797 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

Face FACTS (much different than someone's opinion that does not own any shares):
1)We have done several placements
2)Goshen is working with Biocurex on "something" (IMO either saliva rapid test OR/AND imaging)
3)Inverness sees dollar signs (so do I)
4)Dr Moro is hinting that our lab is working with new samples (IMO a new licensee from the Spain conference).
My last post was deleted unjustly. Kag you ready to step aside?

[Thorn]

GS stated, "The above proves your argument totally wrong. It is obvious that $50,000 was considered important to Abbott and why not make an agreement with Moro to essentially shelve the product forever and Abbott nets another $50,000 in the process."

It proves nothing of the kind. The only thing it proves is that your logic is flawed!

How about this scenario, which is much more plausible, IMO: Dr. Moro wanted to renegotiate a higher percentage off of sales because a lot of the work done on recaf after Abbott signed the licensing agreement was done @ the doctor's facility, largely @ Biocurex's expense. Probably due to the distraction of the G.E. deal that fell apart. Perhaps Dr. Moro used the elimination of the minimum payment as one of the concessions in order to get what he was after in terms of royalties.

[i_invest_utrade]

Abbott has a market cap of $71 billion.

I think $50,000 is small peanuts.